As we have discussed in previous posts, studies have shown that the hormones contained in the birth control product NuvaRing® have been linked to various forms of severe side-effects including: heart attack, stroke, deep vein thrombosis (also known as DVT or blood clots), internal organ damage, myocardial infarction and pulmonary embolism.
At a Case Management Conference on April 16, 2013, Judge Brian Martinotti, who is overseeing all New Jersey state Nuvaring® cases, confirmed that the first trial is still scheduled to begin on June 17, 2013 in Bergen County, New Jersey. If the trial proceeds as scheduled, it will be the first Nuvaring® case to go to trial in the U.S. The outcome will likely impact the thousands of lawsuits pending throughout the country. Currently, there are 20 Nuvaring® cases being prepared for trial in New Jersey, which are considered representative of the hundreds of cases filed in New Jersey.
If you, or someone you know, has experienced adverse effects as a result of using Nuvaring®, you can contact Stark & Stark and speak to one of the Mass Tort/Pharmaceutical Litigation attorneys, free of charge, who can help assess any claims that you might have against the manufacturer of Nuvaring®.